Updates
The following table lists all updates to Edition 203 of the Whole Blood and Components Donor Selection Guidelines (WB‑DSG). The linked Change Notification documents were issued to the UK Blood and Tissue Services (UKBTS) to indicate upcoming changes.
Please note that the dates listed below indicate the formal publication of updated guidelines on the website. The implementation of these guideline changes is the responsibility of each UKBTS and may vary accordingly.
For changes pending publication, see Upcoming changes to the guidelines.
| Change number | Title | Updated | Guidelines affected | Release |
|---|---|---|---|---|
| 27-2026 | Functional neurological disorder (PDF only, 167KB) | 17 September 2026 |
82
|
|
| 28-2026 | Parathyroid disease (PDF only, 169KB) | 17 September 2026 |
82
|
|
| 29-2026 | Polyendocrine metabolic ovarian syndrome (PDF only, 272KB) | 17 September 2026 |
82
|
|
| 32-2026 | Medication and donor eligibility (PDF only, 239KB) | 17 September 2026 |
82
|
|
| 30-2026 | Reversible cerebral vasoconstriction syndrome (PDF only, 190KB) | 17 September 2026 |
82
|
|
| 31-2026 | Transgender and non-binary individuals (PDF only, 213KB) | 17 September 2026 |
82
|
|
| 12-2026 | Mosquito-borne viruses (PDF only, 454KB) | 11 August 2026 |
578166626058
|
|
| 13-2026 | Kidney and bladder disease (PDF only, 455KB) | 11 August 2026 |
81
|
|
| 17-2026 | Eligibility of blood donors undergoing acupuncture (PDF only, 287KB) | 11 August 2026 |
81
|
|
| 18-2026 | Chikungunya vaccination (PDF only, 146KB) | 11 August 2026 |
81
|
|
| 19-2026 | Donation prior to hazardous activities (PDF only, 199KB) | 11 August 2026 |
81
|
|
| 15-2026 | Alopecia treatments (PDF only, 241KB) | 11 August 2026 |
81
|
|
| 16-2026 | Antithrombotic treatments (PDF only, 209KB) | 11 August 2026 |
81
|
|
| 14-2026 | Non-alcoholic fatty liver disease (NAFLD) (PDF only, 184KB) | 11 August 2026 |
81
|
|
| 09-2026 | Changes to be introduced on the new JPAC website (PDF only, 864KB) | 1 May 2026 |
568065625957
|
|
| 10-2026 | Changes to entries in the GDRI and DSGs (PDF only, 418KB) | 1 May 2026 |
568065625957
|
|
| 05-2026 | Bleeding Disorder (PDF only, 283KB) | 17 February 2026 |
79
|
|
| 06-2026 | Transgender and Non-Binary Individuals (PDF only, 210KB) | 17 February 2026 |
79
|
|
| 07-2026 | Testosterone Replacement Therapy (PDF only, 339KB) | 17 February 2026 |
79
|
|
| 26-2025 | Weight Loss Medication (PDF only, 296KB) | 28 August 2025 |
78
|
|
| 27-2025 | Deferral after HAV, HBV and JEV vaccines (PDF only, 371KB) | 28 August 2025 |
78
|
|
| 28-2025 | Hepatitis C (PDF only, 254KB) | 28 August 2025 |
78
|
|
| 29-2025 | Accept and PCOS (PDF only, 342KB) | 28 August 2025 |
78
|
|
| 13-2025 | Injectable Pre-Exposure Prophylaxis (PrEP) for HIV prevention (PDF only, 279KB) | 18 July 2025 |
77
|
|
| 14-2025 | Interpreters (PDF only, 381KB) | 18 July 2025 |
77None
|